133 related articles for article (PubMed ID: 1547350)
1. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation.
Uharek L; Gassmann W; Glass B; Steinmann J; Loeffler H; Mueller-Ruchholtz W
Blood; 1992 Mar; 79(6):1612-21. PubMed ID: 1547350
[TBL] [Abstract][Full Text] [Related]
2. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
[TBL] [Abstract][Full Text] [Related]
3. Effect of post-transplant methotrexate, cyclosporin A and prednisolone on graft rejection after allogeneic bone marrow transplantation.
Uharek L; Gassmann W; Fleischhauer D; Wottge HU; Loeffler H; Mueller-Ruchholtz W
Bone Marrow Transplant; 1991 Jan; 7(1):17-22. PubMed ID: 2043873
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cyclophosphamide, cytarabine, and etoposide as immunosuppressive agents before allogeneic bone marrow transplantation.
Gassmann W; Uharek L; Wottge HU; Schmitz N; Löffler H; Mueller-Ruchholtz W
Blood; 1988 Nov; 72(5):1574-9. PubMed ID: 3052627
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide and ACNU in experimental allogeneic bone marrow transplantation.
Gassmann W; Erbersdobler A; Uharek L; Glass B; Löffler H; Mueller-Ruchholtz W
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S224-7. PubMed ID: 1795012
[TBL] [Abstract][Full Text] [Related]
6. High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.
Gassmann W; Uharek L; Erbersdobler A; Glass B; Wottge HU; Schmitz N; Löffler H; Mueller-Ruchholtz W
Br J Haematol; 1991 Jul; 78(3):310-8. PubMed ID: 1908309
[TBL] [Abstract][Full Text] [Related]
7. Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans.
Martin PJ
J Exp Med; 1993 Aug; 178(2):703-12. PubMed ID: 8101864
[TBL] [Abstract][Full Text] [Related]
8. An immunoablative regimen of fludarabine and cyclophosphamide prevents fully MHC-mismatched murine marrow graft rejection independent of GVHD.
Petrus MJ; Williams JF; Eckhaus MA; Gress RE; Fowler DH
Biol Blood Marrow Transplant; 2000; 6(2A):182-9. PubMed ID: 10816026
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity.
Lapidot T; Lubin I; Terenzi A; Faktorowich Y; Erlich P; Reisner Y
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4595-9. PubMed ID: 2191295
[TBL] [Abstract][Full Text] [Related]
10. Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplantation in a murine model.
Uharek L; Glass B; Gaska T; Gassmann W; Loeffler H; Mueller-Ruchholtz W
Br J Haematol; 1994 Sep; 88(1):79-87. PubMed ID: 7803260
[TBL] [Abstract][Full Text] [Related]
11. Tolerance induction permits the development of graft-versus-host disease: donor-mediated attack following small bowel transplantation in mixed chimeras.
Morrissey NJ; Blom D; Ryan CK; Fisher T; Bronsther O; Orloff MS
Transpl Immunol; 1999 Mar; 7(1):19-25. PubMed ID: 10375074
[TBL] [Abstract][Full Text] [Related]
12. Comparison of potentiality to induce graft-versus-host reaction with small bowel, pancreas/spleen, and liver transplantation in the rat.
Kobayashi E; Kamada N; Enosawa S; Toyama N; Delriviere L; Goto S; Kim YI; Miyata M
Clin Exp Immunol; 1993 Jun; 92(3):527-31. PubMed ID: 8513585
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host reactivity and graft-versus-leukemia effect in murine allogeneic bone marrow chimeras conditioned with total body irradiation or total lymphoid irradiation.
Salam A; Waer M
Transplantation; 1996 Mar; 61(5):826-30. PubMed ID: 8607190
[TBL] [Abstract][Full Text] [Related]
14. Donor gamma delta T lymphocytes promote allogeneic engraftment across the major histocompatibility barrier in mice.
Drobyski WR; Majewski D
Blood; 1997 Feb; 89(3):1100-9. PubMed ID: 9028343
[TBL] [Abstract][Full Text] [Related]
15. Parameters involved in the induction and abrogation of the lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Bruley-Rosset M; Berumen L; Motta R
Immunol Rev; 1985 Dec; 88():59-85. PubMed ID: 2417936
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation.
Truitt RL; Atasoylu AA
Blood; 1991 Jun; 77(11):2515-23. PubMed ID: 2039833
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression.
Tutschka PJ; Santos GW
Transplantation; 1975 Aug; 20(2):101-6. PubMed ID: 241143
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic versus semiallogeneic F1 bone marrow transplantation into sublethally irradiated MHC-disparate hosts. Effects on mixed lymphoid chimerism, skin graft tolerance, host survival, and alloreactivity.
Pierce GE
Transplantation; 1990 Jan; 49(1):138-44. PubMed ID: 2137269
[TBL] [Abstract][Full Text] [Related]
19. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
[TBL] [Abstract][Full Text] [Related]
20. Prevention and restoration of second-set liver allograft rejection in presensitized mice: the role of "passenger" leukocytes, donor major histocompatibility complex antigens, and host cytotoxic effector mechanisms.
Fu F; Li W; Lu L; Thomson AW; Fung JJ; Qian S
Transplantation; 1999 Feb; 67(3):444-50. PubMed ID: 10030293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
